Hypervirulent Klebsiella pneumoniae defined by a five-gene panel predicts mortality in community-acquired bacteremia

Feng-Yee Chang1, L Kristopher Siu2, Jung-Chung Lin1

  • 1Division of Infectious Diseases and Tropical Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical University, Taipei, Taiwan.

Abstract

Insights

The five-gene definition accurately identifies hypervirulent Klebsiella pneumoniae (hvKp) bacteremia, a severe infection linked to increased mortality and morbidity. This molecular marker aids in clinical practice for distinguishing hvKp from classical strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Genetics

Background:

  • Experimental models indicate five specific genes (iucA, iroB, peg-344, rmpA, rmpA2) differentiate hypervirulent Klebsiella pneumoniae (hvKp) from classical strains (cKp).
  • The clinical significance of this five-gene definition in human infections remains to be fully elucidated.

Purpose of the Study:

  • To assess the clinical relevance of the five-gene molecular definition for identifying hvKp in adult patients with K. pneumoniae bacteremia.
  • To compare clinical characteristics, microbiologic features, and mortality rates between hvKp and cKp infections.

Main Methods:

  • A longitudinal study was conducted in an hvKp-endemic region.
  • Klebsiella pneumoniae isolates from bacteremic patients were classified as hvKp or cKp based on the presence of the five target virulence genes via PCR.
  • Clinical data and outcomes, including 28-day mortality, were analyzed using logistic regression.

Main Results:

  • Of 602 patients, 254 had hvKp bacteremia, which was associated with higher rates of abscess formation and prolonged hospital stays.
  • hvKp was identified as an independent predictor of 28-day mortality after adjusting for confounders.
  • Most hvKp isolates remained susceptible to common antimicrobials, while cKp strains with partial gene combinations showed similar characteristics to those lacking all five genes.

Conclusions:

  • The five-gene profile effectively defines a clinically severe subset of K. pneumoniae bacteremia with increased morbidity and mortality.
  • This molecular definition serves as a reliable marker for hvKp in clinical settings, aiding in patient management and understanding disease severity.

Related Concept Videos

Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
634
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
472
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
37